<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04740099</url>
  </required_header>
  <id_info>
    <org_study_id>19-169</org_study_id>
    <nct_id>NCT04740099</nct_id>
  </id_info>
  <brief_title>Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER)</brief_title>
  <acronym>SOONER</acronym>
  <official_title>Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER): Randomized Trial and Embedded Qualitative Study to Compare the Effectiveness of point-of Care Overdose Education and Naloxone Distribution Versus Referral to an Existing Community Program in the Management of Simulated Opioid-associated Resuscitative Emergencies.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unity Health Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Toronto Public Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ontario College of Art and Design (OCAD)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Unity Health Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among people at risk of opioid overdose and receiving care in an academic emergency&#xD;
      department, family practice, opioid substitution clinic or general inpatient units, does&#xD;
      brief opioid overdose resuscitation training and naloxone distribution reduce resuscitation&#xD;
      failures in a simulated overdose even, in comparison with standard-of-care referral to a&#xD;
      local OEND program, within 14 days post-intervention? Can an integrated participant&#xD;
      recruitment and retention strategy recruit approximately 28 eligible participants within 4&#xD;
      weeks and maintain less than 50% attrition rates in the context of a randomized trial on&#xD;
      point-of-care OEND and simulated overdose resuscitation performance in family practice,&#xD;
      emergency department, and addictions settings?&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Study suspended due to operational impediments imposed by COVID-19&#xD;
  </why_stopped>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Pragmatic, multi-site, 2-armed, parallel-group, best available care controlled, analyst- and outcome assessor-blinded, superiority trial with embedded qualitative study.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfactory basic life support performance</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>Satisfactory basic life support performance on a standardized high fidelity overdose simulation, as assessed by the consensus of two trained clinicians.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Performance on basic resuscitation skill: Recognize the Emergency</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>Skill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on basic resuscitation skill: Position the Victim</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>Skill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on basic resuscitation skill: Activate emergency medical services</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>Skill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on basic resuscitation skill: Administer Naloxone</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>Skill performance on device preparation and correct administration will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on basic resuscitation skill: Hand placement</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>Skill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on basic resuscitation skill: chest compressions</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>Skill performance (rate and depth of chest compressions) will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on basic resuscitation skill: continue compressions until end of simulation</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>Skill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance on basic resuscitation skill: order of operations</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>Skill performance will be rated as either satisfactory or unsatisfactory by two trained clinicians. Inter-rater reliability of the assessors for each of the eight secondary outcome skills will be calculated.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Standardized assessor-implemented survey and interview responses to measure overdose-related knowledge and behaviours</measure>
    <time_frame>4-14 days after enrolment</time_frame>
    <description>The questionnaires were developed for the Toronto Public Health OEND program evaluation using data points from other overdose education and naloxone distribution programs and from the validated Opioid Overdose Knowledge and Attitudes Scales (OOKS and OOAS). We also included relevant questions from a national survey of injection drug users (ITRACK, Health Canada) and the CAMH Monitor conducted by the Centre for Addiction and Mental Health (CAMH). The questionnaire items include:&#xD;
Demographics: age, gender, ethnicity, housing status, and neighbourhood&#xD;
Prescription medications&#xD;
Opioid and non-opioid drug use in past 4 weeks: drug, amount, route, frequency&#xD;
Drug use setting: where and with whom opioids were used&#xD;
Periods of abstinence&#xD;
Use of prevention strategies, and speaking to others about overdose or overdose response&#xD;
Knowledge of overdose and naloxone use&#xD;
Status of naloxone kit&#xD;
Willingness and confidence to respond to overdose</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Opioid Use</condition>
  <condition>Opioid-Related Disorders</condition>
  <condition>Opioid Withdrawal</condition>
  <condition>Opioid Overdose</condition>
  <condition>Education</condition>
  <condition>Resusitation</condition>
  <arm_group>
    <arm_group_label>SOONER Training (Intervention)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm receives video training and kit designed by SOONER team.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care training (control)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participant referred to standard of care (community based Naloxone training)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SOONER Video &amp; Kit</intervention_name>
    <description>A brief animated video including basic instructions for opioid overdose response accompanied by a Naloxone kit with an info graphic.</description>
    <arm_group_label>SOONER Training (Intervention)</arm_group_label>
    <other_name>SOONER Naloxone kit</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>A handout including a map and list of locations offering this service.</description>
    <arm_group_label>Standard of care training (control)</arm_group_label>
    <other_name>Community Based Naloxone training referral</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. adults â‰¥16 years of age, and&#xD;
&#xD;
          2. Eligible for overdose education according to criteria adapted from the 2015 American&#xD;
             Heart Association Guidelines by meeting any one or more of the following criteria:&#xD;
&#xD;
               1. has a history of taking opioids at recognized 'high doses' (whether by&#xD;
                  prescription or otherwise, defined as &gt;100mg morphine equivalent per day);&#xD;
&#xD;
               2. has required emergency care for opioid overdose previously;&#xD;
&#xD;
               3. is enrolled in opioid agonist treatment programs, including methadone or&#xD;
                  buprenorphine maintenance programs, or stopped an opioid agonist treatment&#xD;
                  program in the last 6 months;&#xD;
&#xD;
               4. uses non-medical opioids, injects opioids, or acquires opioids from sources other&#xD;
                  than a pharmacy or healthcare setting;&#xD;
&#xD;
               5. has a history of non-medical opioid use who are being released from prison;&#xD;
&#xD;
               6. is receiving prescription opioid therapy with risk factors for adverse effects,&#xD;
                  including i. relevant comorbidities, ii. co-prescriptions of benzodiazepines or&#xD;
                  other sedatives, iii. concomitant ongoing alcohol use, iv. use of prescription&#xD;
                  opioids not as prescribed.&#xD;
&#xD;
               7. is likely to witness an opioid overdose, defined as anyone who lives with or is&#xD;
                  in frequent contact with others who use opioids, or who has previously witnessed&#xD;
                  an opioid overdose.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. plan to move away from Toronto during the study period&#xD;
&#xD;
          2. have no mode of contact or follow-up,&#xD;
&#xD;
          3. have a community do not resuscitate order,&#xD;
&#xD;
          4. have a terminal illness, end-of-life care, or illness likely to result in death within&#xD;
             the study period,&#xD;
&#xD;
          5. are an active or previously practicing healthcare professional or professional first&#xD;
             responder (e.g.: firefighter, police officer, lifeguard, industrial first responder),&#xD;
             or&#xD;
&#xD;
          6. have insufficient English language skills to participate in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carol Strike, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aaron Orkin, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Michael's Hospital, Unity Health Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6G3L8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 4, 2019</study_first_submitted>
  <study_first_submitted_qc>February 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Opioid-Related Disorders</mesh_term>
    <mesh_term>Drug Overdose</mesh_term>
    <mesh_term>Opiate Overdose</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naloxone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All publications will indicate that original de-identified study data and statistical coding is available upon request from the Steering Committee. This information and will be shared freely with corresponding scholars and the public, on request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Available on an ongoing basis upon request</ipd_time_frame>
    <ipd_access_criteria>At the discretion of the research team</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

